Chanda Sanjay 4
4 · AN2 Therapeutics, Inc. · Filed Feb 17, 2023
Insider Transaction Report
Form 4
Chanda Sanjay
Chief Development Officer
Transactions
- Award
Stock Option (right to buy)
2023-02-15+57,950→ 57,950 totalExercise: $14.29Exp: 2033-02-14→ Common Stock (57,950 underlying)
Footnotes (1)
- [F1]The shares subject to the option vest as follows: 1/48 of the shares shall vest on each monthly anniversary as measured from January 1, 2023.